Literature DB >> 11603190

[Contracture of the elbow joint. Etiological review and general treatment concepts].

M Loew1.   

Abstract

The contracture of the elbow joint is a symptom of various local changes and systemic disorders. Appropriate therapy requires a distinct knowledge of the relevant anatomical structures as well as of the etiology and pathogenesis of the functional restriction. Systematically, intrinsic contractures coming from the synovial membrane and intra-articular structures are distinguished from extrinsic contractures involving extra-articular soft tissues. The etiology of heterotopic ossifications is still widely unknown. The classification of the contracture is defined by the by extent of the remaining range of motion. Indications for surgery in severe cases depend on the degree of pain and of functional loss. Surgical arthrolysis includes a large spectrum of possibilities ranging from endocopical procedures to prosthetic joint replacement. Complications are relatively frequent after surgery and the individual gain of function is not always predictable.

Entities:  

Mesh:

Year:  2001        PMID: 11603190     DOI: 10.1007/s001320170045

Source DB:  PubMed          Journal:  Orthopade        ISSN: 0085-4530            Impact factor:   1.087


  4 in total

1.  [Results of open arthrolysis for extrinsic elbow stiffness via radial access. Indications and limits of the procedure].

Authors:  D Schorn; J Steinbeck
Journal:  Orthopade       Date:  2011-04       Impact factor: 1.087

2.  [Open arthrolysis of elbow stiffness].

Authors:  B Ulmar; A Eschler; T Mittlmeier
Journal:  Unfallchirurg       Date:  2012-08       Impact factor: 1.000

3.  [Arthroscopic arthrolysis of the elbow joint].

Authors:  A Achtnich; P Forkel; S Metzlaff; W Petersen
Journal:  Oper Orthop Traumatol       Date:  2013-04       Impact factor: 1.154

4.  [Open arthrolysis of posttraumatic elbow stiffness].

Authors:  K Kolb; H Koller; U Holz; W Kolb; C Windisch; E Markgraf; P A Grützner
Journal:  Unfallchirurg       Date:  2008-05       Impact factor: 1.000

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.